22 The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.

23 Microscopic Evaluation of Ovarian Surface Epithelium Following Treatment with Conjugated Estrogens in a Mouse Model.

24 Ovary starch reserves and pistil development in avocado (Persea americana)

25 Effect of Calcium and Vitamin D Supplements as an Adjuvant Therapy to Metformin on Menstrual Cycle Abnormalities, Hormonal Profile, and IGF-1 System in Polycystic Ovary Syndrome Patients: A Randomized, Placebo-Controlled Clinical Trial

26 The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome

27 Using of rm-anova in r and spss software on the example of prospective analysis of glucose tolerance test results in patients with polycystic ovary syndrome

28 A low glycemic index decreases inflammation by increasing the concentration of uric acid and the activity of glutathione peroxidase (GPX3) in patients with polycystic ovary syndrome (PCOS)

29 Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome

30 Protective effects of vitamin D on ischemia-reperfusion injury of the ovary in a rat model

31 Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study.

32 Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety.

33 Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

34 Expression and localization of inducible and endothelial nitric oxide synthase in the rat ovary. Effects of gonadotropin stimulation in vivo.

35 Risk of Endometriosis and Subsequent Ovary and Breast Cancers in Nurses: A Population-Based Cohort Study in Taiwan.

36 Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.

37 Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).

38 Integration of high-throughput analytics and cell imaging enables direct early productivity and product quality assessment during Chinese Hamster ovary cell line development for a complex multi-subunit vaccine antigen.

39 Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial

40 A Study of the Protective Effects of Vitamin E and Fennel Extract on Mitochondria Changes in Mice Ovary Due to Electromagnetic Field Exposure

41 Correlation between glucose metabolism and serum steroid hormones in patients with polycystic ovary syndrome.

42 Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?

43 Quantitative mass spectrometric analysis to unravel glycoproteomic signature of follicular fluid in women with polycystic ovary syndrome.

44 Gastrin-releasing peptide-like immunoreactivity in porcine follicular fluid and ovary

45 Presence of immunoreactive atrial natriuretic peptide in follicular fluid, ovary and ovarian perfusates

46 The effect of prednisolone on endometrial VGEF concentrations, Gene polymorphisms and pregnancy outcome in women with polycystic ovary syndrome: A retrospective cohort study.

47 Long Non-coding RNA NEAT1 Drives the Development of Polycystic Ovary Syndrome via Sponging Multiple MicroRNAs.

48 Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys

49 Androgen Receptors in Multiple Organ Systems Provide Molecular Gateways to Polycystic Ovary Syndrome

50 Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism

51 Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population‐based study

52 Metabolic Inflexibility Is a Feature of Women With Polycystic Ovary Syndrome and Is Associated With Both Insulin Resistance and Hyperandrogenism

53 Developmental origin of polycystic ovary syndrome - a hypothesis

54 Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome

55 Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome

56 Adipocyte biology in polycystic ovary syndrome

57 Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome

58 Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome

59 Developmental Programming: Excess Weight Gain Amplifies the Effects of Prenatal Testosterone Excess On Reproductive Cyclicity—Implication for Polycystic Ovary Syndrome

60 Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women

61 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

62 Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome

63 Adrenal Hyperandrogenism Is Induced by Fetal Androgen Excess in a Rhesus Monkey Model of Polycystic Ovary Syndrome

64 The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome

65 Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome

66 Developmental origin of polycystic ovary syndrome - a hypothesis

67 Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

68 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

69 Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

70 The genetics of obesity. Lessons for polycystic ovary syndrome

71 Nonhuman primate models of polycystic ovary syndrome

72 Polycystic ovary syndrome and offspring risk of congenital heart defects: a nationwide cohort study

73 Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

74 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

75 Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome

76 Ovulatory effects of flutamide in the polycystic ovary syndrome

77 Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys

78 Menstrual Abnormalities and Polycystic Ovary Syndrome in Women Taking Valproate for Bipolar Mood Disorder

79 Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study

80 Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome

81 Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome

82 Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

83 The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome

84 Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome

85 Lipid and lipoprotein profile in women with polycystic ovary syndrome

86 does carotid intima-media thickness have relationship with polycystic ovary syndrome?

87 effects of nerve growth factor (ngf) on blood vessels area and expression of the angiogenic factors vegf and tgfbeta1 in the rat ovary

88 bilateral sertoli-leydig cell tumor of the ovary: a rare case report

89 the effect of herbal teas on management of polycystic ovary syndrome: a systematic review

90 intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of ohss-like symptoms in rhesus monkeys

91 triunfo arciniegas el amante de madame bovary

92 relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome

93 analysis of the informativeness of melatonin evaluation in polycystic ovary syndrome

94 yolk sac tumor of the ovary in a young girl with tuberous sclerosis: a case report and review of the literature

95 androgen action in the ovary

96 new cell line development for antibody-producing chinese hamster ovary cells using split green fluorescent protein

97 treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice

98 concentração dos hormônios esteroides no fluido folicular de folículos ovarianos maduros e imaturos de pacientes com síndrome dos ovários policísticos submetidas à fertilização in vitro concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization

99 collision tumor of ovary: a rare entity

100 diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome

101 is anti-mullerian hormone a good diagnostic marker for adolescent and young adult patients with polycystic ovary syndrome?

Keyword Connections

Journals

Research Groups

Bibliographies